financetom
Business
financetom
/
Business
/
ChampionX, Schlumberger Shares Move In Opposite Directions After $8B Deal Announcement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ChampionX, Schlumberger Shares Move In Opposite Directions After $8B Deal Announcement
Apr 2, 2024 11:20 AM

ChampionX Corp. shares are trading higher, while Schlumberger Ltd. shares are down after the Texas-based companies announced an all-stock deal.

What Happened: Schlumberger ( SLB ) will acquire ChampionX ( CHX ), and the shareholders will receive 0.735 shares of Schlumberger ( SLB ) in exchange for each ChampionX ( CHX ) share. 

ChampionX ( CHX ) shareholders will own approximately 9% of Schlumberger’s common shares once the deal closes.

Post closure, Schlumberger ( SLB ) expects to realize annual pretax synergies of around $400 million within the first three years through revenue growth and cost savings. 

The transaction is projected to close before 2024, subject to shareholder and regulatory approval. 

Shareholder Return: The company disclosed that it will return $7 billion to shareholders over the next two years. 

Schlumberger ( SLB ) will increase its shareholder returns for 2024 to a target of $3 billion and project returns of $4 billion for 2025. 

Olivier Le Peuch, SLB’s chief executive officer, said, “Our core strategy remains centered on meeting growing energy demand while accelerating decarbonization and emissions reduction through innovation, scale and digitalization in our core oil and gas business. This acquisition will expand SLB’s presence in the less cyclical and growing production and recovery space that is closely aligned with our returns-focused, capital-light strategy,” 

As of Dec. 31, 2023, Schlumberger’s cash and short-term investments stood at $3.99 billion.

Investors can gain exposure to ChampionX ( CHX ) and Schlumberger ( SLB ) via Invesco Oil & Gas Services ETF ( PXJ ) , VanEck Oil Services ETF ( OIH ) , and IShares U.S. Oil Equipment & Services ETF ( IEZ ) .

Price Action: CHX shares are up 8.45% at $38.40 and SLB is down 2.68% at $53.74 on the last check Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bayer cuts FY operating earnings outlook on weak agriculture markets
Bayer cuts FY operating earnings outlook on weak agriculture markets
Nov 11, 2024
FRANKFURT (Reuters) - Bayer on Tuesday lowered its full-year operating earnings guidance, citing weaker agricultural markets in Latin America. The German group said it now expects to generate earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for special items and the impact of currency swings, of between 10.4 billion euros ($11.1 billion) and 10.7 billion euros, down from a...
China military displays upgraded Z-20 helicopter at Zhuhai air show
China military displays upgraded Z-20 helicopter at Zhuhai air show
Nov 11, 2024
* Chinese military showcases naval variant of advanced helicopter * A key step on way to submarine hunting improvements * Z-20 deployments expected to expand, giving navy greater reach By Greg Torode HONG KONG, Nov 12 (Reuters) - With sleek looks mirroring the U.S. UH-60 Black Hawk, the Chinese military's advanced Z-20 helicopter packs a punch but may make its...
Bayer cuts FY operating earnings outlook on weak agriculture markets
Bayer cuts FY operating earnings outlook on weak agriculture markets
Nov 11, 2024
FRANKFURT, Nov 12 (Reuters) - Bayer on Tuesday lowered its full-year operating earnings guidance, citing weaker agricultural markets in Latin America. The German group said it now expects to generate earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for special items and the impact of currency swings, of between 10.4 billion euros ($11.1 billion) and 10.7 billion euros, down...
AstraZeneca invests $3.5 billion for R&D and manufacturing in US
AstraZeneca invests $3.5 billion for R&D and manufacturing in US
Nov 11, 2024
Nov 12 (Reuters) - Astrazeneca ( AZN ) on Tuesday said it was investing $3.5 billion in the United States to expand its research and development (R&D) and manufacturing by the end of 2026. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved